Retraction Note: Extended-spectrum β-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit (Journal of Perinatology, (2008), 28, 10, (685-690), 10.1038/jp.2008.73);Extended-spectrum β-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit

Journal of Perinatology

Volumn 28, Issue 10, 2008, Pages 685-690

  Abdel Hady, H ^a   Hawas, S ^b   El Daker, M ^b   El Kady, R ^b  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE SHV; BETA LACTAMASE SHV 1; BETA LACTAMASE SHV 2; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

AMPLICON; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; BIRTH WEIGHT; BLOOD SAMPLING; CAREGIVER; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE SURVEILLANCE; DISK DIFFUSION; ENDOTRACHEAL TUBE; ENTEROBACTER INFECTION; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC SCREENING; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN CARE; NEWBORN INFECTION; NEWBORN SCREENING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEPSIS; TOTAL PARENTERAL NUTRITION; URINALYSIS;

EID: 53949101277     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/s41372-023-01702-8     Document Type: Erratum

References (28)

1. Brady MT. Health care-associated infections in the neonatal intensive care unit. Am J Infect Control 2005; 33: 268-275.
2. Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ. Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J Hosp Infect 2001; 47: 223-229.
3. Boo NY, Ng SF, Lim VK. A case-control study of risk factors associated with rectal colonization of extended-spectrum beta-lactamase producing Klebsiella sp. in newborn infants. J Hosp Infect 2005; 61 68-74.
4. Linkin DR, Fishman NO, Patel JB, Merrill JD, Lautenbach E. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004; 25: 781-783.
5. Pessoa-Silva CL, Meurer Moreira B, Camara Almeida V, Flannery B, Almeida Lins MC, Mello Sampaio JL et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Risk factors for infection and colonization. J Hosp Infect 2003; 53: 198-206.
6. Miranda G, Castro N, Lea B, Valenzuela A, Garza-Ramos U, Rojas T et al. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum beta-lactamase in a Mexican pediatric hospital. J Clin Microbiol 2004; 42: 30-35.
7. Gastmeier P, Groneberg K, Weist K, Ruden H. A cluster of nosocomial Klebsiella pneumoniae bloodstream infections in a neonatal intensive care department: Identification of transmission and intervention. Am J Infect Control 2003; 31: 424-430.
8. Bagattini M, Crivaro V, Di Popolo A, Gentile F, Scarcella A, Triassi M et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Antimicrob Chemother 2006; 57: 979-982.
9. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
10. Al-Jasser AM. Extended-spectrum beta-lactamases (ESBLs): A global problem. Kuwait Med J 2006; 38: 171-185.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
12. Koneman EW, Allen SD, Janda WM, Schreckenberger RC, Winn WC. Introduction to microbiology, part II: Guidelines for the collection, transport, processing, analysis and reporting of cultures from specific specimen sources. In: Koneman EW, Allen SD, Janda WM, Schreckenberger RC, Winn WC (eds). Color Atlas and Textbook of Diagnostic Microbiology, 5th edn. Lippincot-Raven: Philadelphia, 1997, pp 121-170.
13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, 9th edn. Clinical and Laboratory Standards Institute document M2-A9 (ISBN 1-56238-586-0) Clinical and Laboratory Standards Institute: Wayne, Pennsylvania, USA, 2006.
14. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-878.
15. Chen WP, Kuo TT. A simple and rapid method for the preparation of gram-negative bacterial genomic DNA. Nucleic Acids Res 1993; 21 2260.
16. Haley RW, Gaynes RP, Aber RC, Bennet JV. Surveillance of nosocomial infections. In: Bennet JV, Brachman PS (eds). Hospital Infections, 3rd edn. Little, Brown and Company: Boston, MA, 1992, pp 79-108.
17. Moore KL, Kainer MA, Badrawi N, Afifi S, Wasfy M, Bashir M et al. Neonatal sepsis in Egypt associated with bacterial contamination of glucose-containing intravenous fluids. Pediatr Infect Dis J 2005; 24: 590-594.
18. Woodford N, Dallow JW, Hill RL, Palepou MF, Pike R, Ward, ME et al. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int J Antimicrob Agents 2007; 29: 456-459.
19. Jain A, Mondal R. Prevalence & antimicrobial resistance pattern of extended spectrum beta-lactamase producing Klebsiella spp isolated from cases of neonatal septicaemia. Indian J Med Res 2007; 125 89-94.
20. Lee K, Yong D, Choi YS, Yum JH, Kim JM, Woodford N et al. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Int J Antimicrob Agents 2007; 29: 201-206.
21. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1991; 35: 1697-1704.
22. Schmitt J, Jacobs E, Schmidt H. Molecular characterization of extended-spectrum beta-lactamases in Enterobacteriaceae from patients of two hospitals in Saxony, Germany. J Med Microbiol 2007; 56: 241-249.
23. Martins-Loureiro M, de Moraes BA, de Mendonca VL, Rocha-Quadra MR, dos Sanitos-Pinheiro G, Dutra-Asensi M. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from neonatal intensive care unit patients involved in hospital infection cases in Rio de Janeiro, Brazil. Rev Latinoam Microbiol 2001; 43: 88-95.
24. Crivaro V, Bagattini M, Salza MF, Raimondi F, Rossano F, Triassi M et al. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Hosp Infect 2007; 67: 135-141.
25. Kuo KC, Shen YH, Hwang KP. Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: A case-control retrospective study in a medical center in southern Taiwan. J Microbiol Immunol Infect 2007; 40 248-254.
26. Huang Y, Zhuang S, Du M. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China. Infection 2007; 35: 339-345.
27. Ntagiopoulos PG, Paramythiotou E, Antoniadou A, Giamarellou H, Karabinis A. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece. Int J Antimicrob Agents 2007; 30: 360-365.
28. Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR 2002; 51: 1-45.